Related Funds
Funds with similar focus
Fund Name | Location |
Agate Medical Investments | Israel, Tel Aviv, Tel Aviv District |
AnswersMedia | Chicago, Illinois, United States |
Asgard Capital | Brandenburg, Germany, Potsdam |
China and Portuguese-speaking Countries Cooperation and Development | - |
China Merchants Technology Holdings | China, Guangdong, Shenzhen |
Cobre Capital | Arizona, Scottsdale, United States |
COERA | Cluj, Cluj-Napoca, Romania |
London & Scottish Investment Partners | City of Edinburgh, Scotland, United Kingdom |
MTI | Japan, Shinjuku |
Sagus Capital Partners | Incline Village, Nevada, United States |
Shanghai Anting Industrial Development Co., Ltd. | China, Shanghai |
SIDBI Innovation & Incubation Centre (SIIC) | India, Kanpur, Uttar Pradesh |
SMS Securities | Switzerland, Zürich, Zurich |
SR Innovation Exchange | India, Telangana, Warangal |
TukkuHeino | - |
Wealth Well | Ar Riyad, Riyadh, Saudi Arabia |
Xpreneurs | Bayern, Germany, München |
Zhili Zhenzhu | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
AsclepiX Therapeutics | $35M | 24 Jun 2020 | Baltimore, Maryland, United States | ||
$75M | 18 Jun 2019 | Maryland, United States | |||
NexImmune | $23M | 02 Jan 2018 | Maryland, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
AsclepiX Therapeutics | $35M | 24 Jun 2020 | Baltimore, Maryland, United States | ||
$75M | 18 Jun 2019 | Maryland, United States | |||
NexImmune | $23M | 02 Jan 2018 | Maryland, United States |